Platform|API|Archive|Contact

Humanexa SignalsPharmaceutical Intelligence

FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Pricing
Access
Commercial
Launch Tracking

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

Regulatory
Clinical
Competitive
Markets
M&A Watch
Strategy
Catalyst Tracker

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Company

Epic Pharma

Pharmaceutical intelligence for Epic Pharma with 11 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 7
Catalysts: 4
Assets: 6

Recent signals(7)

RegulatoryAugust 3, 2026

FDA Submission Update for Leucovorin Calcium by Epic Pharma

Epic Pharma's ANDA074544 for Leucovorin Calcium has received an Abbreviated Approval (AP) status.

RegulatoryJuly 22, 2026

FDA Accepts Supplement for Furosemide by Epic Pharma

The FDA has accepted a supplemental application for Furosemide submitted by Epic Pharma.

RegulatoryJuly 12, 2026

FDA Grants AP Status to Epic Pharma's Leucovorin Calcium Supplement

The FDA has granted approval status (AP) for Epic Pharma's ANDA074544 for Leucovorin Calcium.

July 8, 2026

FDA Grants Approval for Cetrorelix Acetate by Epic Pharma

The FDA has granted approval for the ANDA218740 application for Cetrorelix Acetate submitted by Epic Pharma.

RegulatoryJune 29, 2026

FDA Acceptance of Supplement for Oxycodone Hydrochloride by Epic Pharma

The FDA has accepted a supplemental application for Oxycodone Hydrochloride submitted by Epic Pharma.

RegulatoryJune 25, 2026

FDA Accepts Supplemental Application for Tapentadol Hydrochloride by Epic Pharma

The FDA has accepted a supplemental application for Tapentadol Hydrochloride submitted by Epic Pharma.

RegulatoryJune 22, 2026

FDA Accepts Supplement for Labetalol Hydrochloride by Epic Pharma

The FDA has accepted a supplemental application for Labetalol Hydrochloride submitted by Epic Pharma.

Upcoming catalysts

No catalysts indexed for this entity yet.

Regulatory activity(7)

RegulatoryAugust 3, 2026

FDA Submission Update for Leucovorin Calcium by Epic Pharma

Epic Pharma's ANDA074544 for Leucovorin Calcium has received an Abbreviated Approval (AP) status.

RegulatoryJuly 22, 2026

FDA Accepts Supplement for Furosemide by Epic Pharma

The FDA has accepted a supplemental application for Furosemide submitted by Epic Pharma.

RegulatoryJuly 12, 2026

FDA Grants AP Status to Epic Pharma's Leucovorin Calcium Supplement

The FDA has granted approval status (AP) for Epic Pharma's ANDA074544 for Leucovorin Calcium.

RegulatoryJuly 8, 2026

FDA Grants Approval for Cetrorelix Acetate by Epic Pharma

The FDA has granted approval for the ANDA218740 application for Cetrorelix Acetate submitted by Epic Pharma.

RegulatoryJune 29, 2026

FDA Acceptance of Supplement for Oxycodone Hydrochloride by Epic Pharma

The FDA has accepted a supplemental application for Oxycodone Hydrochloride submitted by Epic Pharma.

RegulatoryJune 25, 2026

FDA Accepts Supplemental Application for Tapentadol Hydrochloride by Epic Pharma

The FDA has accepted a supplemental application for Tapentadol Hydrochloride submitted by Epic Pharma.

RegulatoryJune 22, 2026

FDA Accepts Supplement for Labetalol Hydrochloride by Epic Pharma

The FDA has accepted a supplemental application for Labetalol Hydrochloride submitted by Epic Pharma.

Clinical activity

No signals indexed for this entity yet.

Competitive activity

No signals indexed for this entity yet.

Assets

Cetrorelix Acetate →

Labetalol Hydrochloride →

Oxycodone Hydrochloride →

Tapentadol Hydrochloride →

Therapeutic areas

Beta-blocker →

Cardiovascular →

Cardiovascular · Beta-blocker →

GnRH Antagonist →

Pain Management →

Pain Management · Opioid →

Reproductive Health →

Reproductive Health · GnRH Antagonist →

Supportive Care →

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.